Effects of chronic diazepam treatment and withdrawal on avoidance behavior

Date

1999-06-01

Author

Ayvasik, B
Zagli, U
Palaoglu, O
Soygur, H
Ayhan, IH

Metadata

Show full item record

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Item Usage Stats

252
views

0
downloads

The present study was designed to evaluate the effects of chronic diazepam (DZ) treatment with low doses and diazepam withdrawal on the two-way shuttle-box avoidance performance in rats. After 24 rats were randomly assigned into three groups (I mg/kg DZ, 2 mg/kg DZ and control groups), all animals were trained to avoid from an electrical foot shock (0.8 mA) delivered through the grid floor by crossing to the other compartment of the box. Following the avoidance training, the first group received I mg/kg DZ (DZ1), the second group received 2 mg/kg DZ (DZ2), and the control group (CONT group) was given a vehicle chronically for 28 days. All rats were tested on the 1(st), 7(th), 14(th), 21th and 28(th) days of chronic treatment. Following chronic DZ treatment, two weeks of withdrawal from chronic DZ treatment started and all animals were tested on the 1(st), 4(th), 7(th), and 14(th) days of withdrawal. Acute administration of DZ did not produce any impairment on avoidance performance. However all groups showed a significant increment in avoidance performance for the first day of drug administration. Neither chronic administration of DZ nor withdrawal from it had a significant effect on avoidance performance. These findings were discussed by faking potential confounding variables, such as subject loss throughout the experiment, ceiling effect of training, anxiogenic effect of beginning, and discontinuation of injection, into consideration.

Subject Keywords

Diazepam, Two-way shuttle-box, Withdrawal, Tolerance, Avoidance

URI

https://hdl.handle.net/11511/68215

Journal

TURK PSIKOLOJI DERGISI

Collections

Department of Psychology, Article

Suggestions

OpenMETU
Core

Effects of risperidone treatment on the expression of hypothalamic neuropeptide in appetite regulation in Wistar rats Kursungoz, Canan; AK, MEHMET; Yanık, Tülin (2015-01-30) Although the use of atypical antipsychotic drugs has been successful in the treatment of schizophrenia, they can cause some complications in the long-term use, including weight gain. Patients using these drugs tend to disrupt treatment primarily due to side effects. The atypical antipsychotic mechanism of action regulates a number of highly disrupted neurotransmitter pathways in the brains of psychotic patients but may also cause impairment of neurohorrnonal pathways in different brain areas. In this study,...
Effect of arachidonic acid on specific binding of [H-3]naloxone to opioid receptors Apaydin, S; Öktem, Hüseyin Avni (2000-01-01) The effects of arachidonic acid (AA) on binding of [H-3]naloxone to the agonist and antagonist configurations of opioid receptors were investigated in rat brain. Equilibrium binding parameters of the agonist and antagonist configurations of the receptors were evaluated from homologue displacement data in the presence or absence of AA. Addition of AA at a concentration of 0.6 mM (1.5 mu mole/mg of protein) reduced by 22% and 53% the maximal number of binding sites (B-max) respectively in the absence or prese...
Impacts of olanzapine coupled with or without metformin administration on the expression of cannabinoid and melanocortin receptors in rats Jacob Alis, Aditya Kemal; Yanık, Tülin; Department of Biochemistry (2017) Secondary generation antipsychotics (SGA) were lauded as an improvement over first generation antipsychotics (FGA) in terms of both efficacies and reduced metabolic side effects such as obesity and diabetic phenotypes (1). However, SGAs were still plagued by a plethora of aforementioned metabolic side effects, albeit at reduced severity compared to the FGAs. While the side effects of SGAs had been extensively investigated through different experiments, the exact mechanism of the SGAs on the metabolic disord...
Determination of hypothalamic neuropeptide levels involved in appetite regulation in atypical antipsychotic drug, risperidone treatment Kurşungöz, Canan; Yanık, Tülin; Department of Biology (2012) Although the use of atypical antipsychotic drugs is successful in the treatment of schizophrenia, they cause complications in the long term use that is mainly weight gain. In this study, circulating levels of hypothalamic neuropeptides/hormones, which are related to appetite regulation; neuropeptide Y (NPY), alpha melanocyte stimulating hormone (α-MSH), cocaine and amphethamine regulated transcript (CART) and plus leptin in male schizophrenic patients who were treated with an atypical antipsychotic drug, ri...
Alterations of hypothalamic neuropeptides involved in food intake and appetite in olanzapine monotherapy Sezlev, Deniz; Yanık, Tülin; Department of Biology (2012) The mechanism of weight gain due to treatment with olanzapine, a serotonin receptor antagonist, has not been fully understood. Weight gain and food intake are under the control of neuropeptides/hormones, POMC (proopiomelanocortin), CART (cocaine and amphetamine regulated transcript), AgRP (Agouti-related peptide) and NPY (neuropeptide Y) that are synthesized and secreted from the arcuate nucleus (ARC) of hypothalamus. In this study, the altereration of the ARC neuropeptide/hormone levels both in humans and ...

Citation Formats

B. Ayvasik, U. Zagli, O. Palaoglu, H. Soygur, and I. Ayhan, “Effects of chronic diazepam treatment and withdrawal on avoidance behavior,” TURK PSIKOLOJI DERGISI, pp. 61–69, 1999, Accessed: 00, 2020. [Online]. Available: https://hdl.handle.net/11511/68215.